BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2016
View Archived Issues
FDA grants orphan drug designation to gene therapy for the treatment of retinitis pigmentosa
Read More
MorphoSys initiates phase II/III trial of MOR-208 with bendamustine in DLBCL
Read More
FDA confers orphan drug status to angiogenesis inhibitor nintedanib
Read More
FDA approves first compassionate use of masitinib for ALS
Read More
Alexion Pharmaceuticals' ALXN-1540 receives U.S. orphan drug designation for Crigler-Najjar syndrome
Read More
Mazindol granted orphan drug designation in U.S.
Read More
Gilead Sciences and Institute of Organic Chemistry and Biochemistry patent anti-HIV agents
Read More
Pontificia Universidad Catolica de Chile patent reveals antineoplastic compounds
Read More
Celldex Therapeutics initiates phase I/II study of CDX-014 in renal cell carcinoma
Read More
MIT and The Broad Institute report dopamine D2 receptor ligands
Read More
MAPK inhibitors described in Axikin Pharmaceuticals patent
Read More
Kyoto University and Nagasaki University disclose gamma delta T cell inducers
Read More
Coherus BioSciences' study of pegfilgrastim biosimilar meets coprimary endpoints
Read More
AZD-5363 after radiotherapy improves head and neck cancer tumor control in vivo but not in vitro
Read More
AdAlta to raise funds to support clinical studies of candidate for IPF
Read More
European Investment Bank loan supports R&D activities at Valneva
Read More
NIH grant supports Cellex's development of rapid test for detection of CPOs
Read More
Novel multiple sclerosis susceptibility loci identified in GWAS
Read More
Cell Medica announces acquisition of Delenex Therapeutics
Read More
FDA approves monthly single-dose evolocumab system
Read More
rTSST-1v vaccine shows potential for the prevention of TSST-1-dependent disease
Read More
Leukemia & Lymphoma Society makes second investment in Kiadis to support development of ATIR-101
Read More
FDA approves Xiidra to treat signs and symptoms of dry eye disease
Read More
Sucampo Pharmaceuticals decides to discontinue development of cobiprostone
Read More
Cantabio and Purdue Research Foundation to collaborate on DJ-1-targeting drugs
Read More
AbbVie's ABT-414 wins rare pediatric disease designation from FDA
Read More
AOP Orphan Pharmaceuticals' Rapibloc approved in Europe
Read More
WARS2 gene linked to angiogenesis within and outside the heart
Read More
